Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CERo Therapeutics Inc.

    NASDAQ: CERO · Real-Time Price · USD
    20.08
    13.21 (192.37%)
    At close: Jun 17, 2025, 3:59 PM

    CERo Therapeutics Statistics

    Share Statistics

    CERo Therapeutics has 516.09K shares outstanding. The number of shares has increased by 1911.64% in one year.

    Shares Outstanding

    n/a
    		 516.09K

    Shares Change (YoY)

    n/a
    		 1911.64%

    Shares Change (QoQ)

    n/a
    		 57.91%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 317.54K

    Failed to Deliver (FTD) Shares

    n/a
    		 14,349

    FTD / Avg. Volume

    n/a
    		 14.18%

    Short Selling Information

    The latest short interest is 640.69K, so 155.47% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 640.69K

    Short % of Shares Out

    n/a
    		 155.47%

    Short % of Float

    n/a
    		 166.79%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.45 and the forward PE ratio is -0.28. CERo Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.45

    Forward PE

    n/a
    		 -0.28

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -1.84

    P/FCF Ratio

    n/a
    		 -0.6

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CERo Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.5, with a Debt / Equity ratio of -0.83.

    Current Ratio

    n/a
    		 0.5

    Quick Ratio

    n/a
    		 0.5

    Debt / Equity

    n/a
    		 -0.83

    Debt / EBITDA

    n/a
    		 -0.24

    Debt / FCF

    n/a
    		 -0.27

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-966,500

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -99.03% in the last 52 weeks. The beta is 0.43, so CERo Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.43

    52-Week Price Change

    n/a
    		 -99.03%

    50-Day Moving Average

    n/a
    		 12.55

    200-Day Moving Average

    n/a
    		 113.25

    Relative Strength Index (RSI)

    n/a
    		 29.68

    Average Volume (20 Days)

    n/a
    		 101,166

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -15.3M

    Net Income

    n/a
    		 -7.73M

    EBITDA

    n/a
    		 -6.57M

    EBIT

    n/a
    		 -7.73M

    Earnings Per Share (EPS)

    n/a
    		 -18.15
    Full Income Statement

    Balance Sheet

    The company has 3.33M in cash and 1.58M in debt, giving a net cash position of 1.75M.

    Cash & Cash Equivalents

    n/a
    		 3.33M

    Total Debt

    n/a
    		 1.58M

    Net Cash

    n/a
    		 1.75M

    Retained Earnings

    n/a
    		 -70.92M

    Total Assets

    n/a
    		 7.99M

    Working Capital

    n/a
    		 -2.09M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -5.79M and capital expenditures -1, giving a free cash flow of -5.79M.

    Operating Cash Flow

    n/a
    		 -5.79M

    Capital Expenditures

    n/a
    		 -1

    Free Cash Flow

    n/a
    		 -5.79M

    FCF Per Share

    n/a
    		 -9.99
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CERO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CERO is $60, which is 779.8% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $60

    Price Target Difference

    n/a
    		 779.8%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 13, 2025. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jun 13, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -19.24

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist